The global Cannabigerol (CBG) market size is predicted to grow from US$ 9113 million in 2025 to US$ 20450 million in 2031; it is expected to grow at a CAGR of 14.4% from 2025 to 2031.

Cannabigerol (CBG) is one of more than 120 identified cannabinoid compounds found in the plant genus Cannabis. Cannabigerol is the decarboxylated form of cannabigerolic acid, the parent molecule from which other cannabinoids are synthesized. Cannabigerol is a minor constituent of cannabis. During plant growth, most of the cannabigerol is converted into other cannabinoids, primarily tetrahydrocannabinol (THC) or cannabidiol (CBD), leaving about 1% cannabigerol in the plant.

Growing Interest in CBG: CBG gained attention as a non-psychoactive cannabinoid that could have various potential health benefits. Researchers were studying its potential anti-inflammatory, analgesic, and neuroprotective properties, which generated interest from both the medical and wellness sectors.

Product Development: CBD and THC had dominated the market, but CBG was emerging as a popular alternative. Companies were investing in research and development to create CBG-rich strains and products, including oils, capsules, topicals, and edibles.

Market Expansion: As the legal landscape for cannabis and hemp continued to evolve, CBG products were becoming more widely available. States and countries were revising their regulations to accommodate CBG, potentially leading to market expansion.

Consumer Awareness: There was a growing awareness among consumers about CBG and its potential benefits. Educational efforts and marketing campaigns were helping people understand the differences between cannabinoids like CBD, THC, and CBG.

Price Fluctuations: CBG-rich strains were still relatively rare, which could lead to price fluctuations. The cost of CBG products might be higher compared to CBD due to the challenges of cultivating CBG-rich plants.

Infinity Market Research newest research report, the ?Cannabigerol (CBG) Industry Forecast? looks at past sales and reviews total world Cannabigerol (CBG) sales in 2024, providing a comprehensive analysis by region and market sector of projected Cannabigerol (CBG) sales for 2025 through 2031. With Cannabigerol (CBG) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabigerol (CBG) industry.

This Insight Report provides a comprehensive analysis of the global Cannabigerol (CBG) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cannabigerol (CBG) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cannabigerol (CBG) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabigerol (CBG) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabigerol (CBG).

This report presents a comprehensive overview, market shares, and growth opportunities of Cannabigerol (CBG) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Full Spectrum CBG Oil
    THC-free CBG Tincture
    CBG Isolate
    CBG Softgel Capsules
    Others

Segmentation by Application:

    Medicinal
    Relieve Stress
    Pain Relief
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Hempsana Holdings
    Willow Biosciences
    Precision Plant Molecules
    Bright Green Corporation
    Hemptown
    Charlottes Web
    Green Road
    Demetrix
    Canatura
    CannaCare
    FAB CBD
    CBDistillery
    Medterra CBD
    NuLeaf Naturals
    Lazarus Naturals
    Avikana
    Incr-edibles
    Vida Optima

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cannabigerol (CBG) market?
What factors are driving Cannabigerol (CBG) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cannabigerol (CBG) market opportunities vary by end market size?
How does Cannabigerol (CBG) break out by Type, by Application?